The Journal of infectious diseases
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy.
Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.
Type I Interferon is Pathogenic During Chronic Mycobacterium africanum Infection.
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children.
Soluble CD163 and Clinical Outcomes in Treated HIV Infection: Insights Into Mechanisms.
Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10.
